Brasília – The Drug Market Regulation Chamber (CMED) imposes more than BRL 13.5 million in fines on pharmaceutical distributors for offering medicines above regulated price ceilings, reinforcing its stance on stricter market oversight. Sanctioned companies include Imediata Distribuidora de Produtos para a Saúde, Fabmed Distribuidora Hospitalar, Panorama Comércio de Produtos Médicos e Farmacêuticos, and Realmed Distribuidora, all penalized for exceeding the Price Factory (PF) and Maximum Price to Government (PMVG) limits.

Regulators argue that pricing violations constitute abusive practices regardless of procurement outcomes and must be rigorously addressed to ensure fair access to medicines. The cases are part of a broader set of 54 administrative proceedings reviewed by CMED, highlighting ongoing tensions between regulatory enforcement and market dynamics in Brazil’s pharmaceutical sector.

Source: Agência Brasil